Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 5.63 is 37% above its 5-year average of 4.12, around the middle of its 5-year range (1.65–9.48).
As of the fiscal period ended Tuesday, June 30, 2026. 24.62% above its 12-month average of 4.52.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 5.63.
QUICK RATIO (ACID-TEST)
5.63
QUICK RATIO (ACID-TEST) AVG TTM
4.52
QUICK RATIO (ACID-TEST) AVG 3Y
4.39
QUICK RATIO (ACID-TEST) AVG 5Y
4.12
QUICK RATIO (ACID-TEST) AVG 10Y
3.81
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+24.62%
CURRENT VS 3Y AVG
+28.28%
CURRENT VS 5Y AVG
+36.74%
CURRENT VS 10Y AVG
+47.93%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
2.99
median of 497 covered companies
CURRENT VS SECTOR MEDIAN
+88.38%
vs the sector median at left
Adial Pharmaceuticals, Inc.
Market Cap
$11.42M
Quick Ratio (Acid-Test)
5.63
TTM Avg
4.52
3Y Avg
4.39
5Y Avg
4.12
Market Cap
$11.41M
Quick Ratio (Acid-Test)
1.08
TTM Avg
1.28
3Y Avg
1.24
5Y Avg
1.80
Market Cap
$11.21M
Quick Ratio (Acid-Test)
8.97
TTM Avg
5.46
3Y Avg
4.04
5Y Avg
3.77
Market Cap
$11.01M
Quick Ratio (Acid-Test)
10.57
TTM Avg
6.64
3Y Avg
7.08
5Y Avg
4.73
Market Cap
$11.94M
Quick Ratio (Acid-Test)
1.08
TTM Avg
1.32
3Y Avg
1.15
5Y Avg
1.64
Market Cap
$11.95M
Quick Ratio (Acid-Test)
2.64
TTM Avg
6.08
3Y Avg
6.44
5Y Avg
4.53
Market Cap
$10.74M
Quick Ratio (Acid-Test)
1.37
TTM Avg
0.79
3Y Avg
1.08
5Y Avg
1.46
Market Cap
$12.46M
Quick Ratio (Acid-Test)
0.50
TTM Avg
1.75
3Y Avg
2.03
5Y Avg
3.39
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Adial Pharmaceuticals, Inc. (ADIL) | $11.42M | 5.63 | 4.52 | 4.39 | 4.12 |
| Biofrontera Inc. (BFRI)vs › | $11.41M | 1.08 | 1.28 | 1.24 | 1.80 |
| Kiora Pharmaceuticals, Inc. (KPRX)vs › | $11.21M | 8.97 | 5.46 | 4.04 | 3.77 |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs › | $11.01M | 10.57 | 6.64 | 7.08 | 4.73 |
| IRIDEX Corporation (IRIX)vs › | $11.94M | 1.08 | 1.32 | 1.15 | 1.64 |
| CytoMed Therapeutics Limited (GDTC)vs › | $11.95M | 2.64 | 6.08 | 6.44 | 4.53 |
| BioVie Inc. (BIVI)vs › | $10.86M | 3.59 | 6.34 | 4.40 | 4.46 |
| Cerenome, Inc. (CNSY)vs › | $10.74M | 1.37 | 0.79 | 1.08 | 1.46 |
| Cytosorbents Corporation (CTSO)vs › | $12.46M | 0.50 | 1.75 | 2.03 | 3.39 |
| Caring Brands, Inc. (CABR)vs › | $10.27M | 4.93 | 13.09 | 13.09 | 13.09 |
Quick Ratio
5.63
Excludes inventory
Current Ratio
5.63
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 5.63 |
| 2026-03-31 | 3.18 |
| 2025-12-31 | 4.42 |
| 2025-09-30 | 4.34 |
| 2025-06-30 | 5.02 |
| 2025-03-31 | 1.99 |
| 2024-12-31 | 4.16 |
| 2024-09-30 | 6.78 |
| 2024-06-30 | 5.69 |
| 2024-03-31 | 9.48 |
| 2023-12-31 | 4.90 |
| 2023-09-30 | 2.15 |
| 2023-06-30 | 4.43 |
| 2023-03-31 | 1.65 |
| 2022-12-31 | 2.67 |
| 2022-09-30 | 5.10 |
| 2022-06-30 | 5.32 |
| 2022-03-31 | 5.97 |
| 2021-12-31 | 2.37 |
| 2021-09-30 | 4.08 |
| 2021-06-30 | 2.53 |
| 2021-03-31 | 3.02 |
| 2020-12-31 | 3.41 |
| 2020-09-30 | 7.48 |
| 2020-06-30 | 13.89 |
| 2020-03-31 | 15.23 |
| 2019-12-31 | 14.24 |
| 2019-09-30 | 12.23 |
| 2019-06-30 | 17.05 |
| 2019-03-31 | 36.61 |
| 2018-12-31 | 18.19 |
| 2018-09-30 | 16.25 |
| 2018-06-30 | 0.12 |
| 2018-03-31 | 0.05 |
| 2017-12-31 | 0.03 |
| 2017-09-30 | 0.10 |
| 2017-06-30 | 0.28 |
| 2017-03-31 | 0.24 |
| 2016-12-31 | 0.55 |
| 2016-09-30 | 0.00 |
| 2016-06-30 | 0.00 |
| 2016-03-31 | 0.00 |
